Just a moment...

Top
FeedbackReport
×

By creating an account you can:

Logo TaxTMI
>
Feedback/Report an Error
Email :
Please provide your email address so we can follow up on your feedback.
Category :
Description :
Min 15 characters0/2000
Make Most of Text Search
  1. Checkout this video tutorial: How to search effectively on TaxTMI.
  2. Put words in double quotes for exact word search, eg: "income tax"
  3. Avoid noise words such as : 'and, of, the, a'
  4. Sort by Relevance to get the most relevant document.
  5. Press Enter to add multiple terms/multiple phrases, and then click on Search to Search.
  6. Text Search
  7. The system will try to fetch results that contains ALL your words.
  8. Once you add keywords, you'll see a new 'Search In' filter that makes your results even more precise.
  9. Text Search
Add to...
You have not created any category. Kindly create one to bookmark this item!
Create New Category
Hide
Title :
Description :
❮❮ Hide
Expand ❯❯
Close ✕
🔎 News - Adv. Search
    All Roads in Performance Marketing Ecosystem to Converge at CLICK 2025
    ASCI asks media firms to label paid posts shared on social media handles
    Puravankara Celebrates 50 Glorious Years with a Special ‘My Stamp’ Issued by India Post
    India builds 10,660 Km of highways in FY25, Eyes Rs 3 trillion push, Road Minister Ajay Tamta to boost road reforms at RAHSTA Expo 2025
    Senco Gold Q1FY'26 consolidated net profit surges to Rs 104.6 crore
    Wonderful Pistachios Highlights Power of Protein at Indian Healthy Snacking Summit 2025
    NX Group to Exhibit at SEMICON India 2025 in New Delhi
    US tariff impact not to last more than 6 months; pvt sector has to do more for India: CEA
    Perfios Launches CAM AI, Powers 85% Faster Underwriting
    Gold falls Rs 500 to Rs 1,01,020/10 g, silver trades flat
    US tariffs not to impact India's growth; no threat to positive outlook on sovereign rating: S&P
    SBI Life launches 'SBI Life - Smart Shield Plus', a future-ready term insurance plan designed for consumer's evolving insurance needs
    Balu Forge Industries Ltd. Announces Q1FY26 Financial Results
    COLGATE DENTAL VEER ANTHEM LAUNCHED TO EMPOWER KIDS TO BE THEIR OWN HEROES OF ORAL HEALTH
    CBAM to cost India 0.03 pc of GDP, domestic carbon tax can blunt impact: Analysis
    slice brings UPI-powered bank branch and ATM to Gurugram
    IIM Calcutta launches Advanced Programme in Smart Manufacturing Leadership to drive India's Industry 4.0 revolution
    Rupee rises 20 paise to close at 87.43 against US dollar
    KPMG in India announces StepOut as the winner of the 5th edition of 'KPMG Private Enterprise Global Tech Innovator Competition (GTIC)' – India Finale
    Sensex climbs 304 pts, Nifty closes above 24,600 as steady US inflation fuels global rally

Are you sure you want to delete "My most important" ?

NOTE:

News

Back

All News

Showing Results for : Category : All
Reset Filters
Showing
Records
ExpandCollapse

    News

    Back

    All News

    Showing Results for : Category : AllReset Filters
    Case ID :

    Remedium Lifecare: Ride the Pharma Wave with Our Rights Issue!

    April 29, 2025

    📋
    Contents
    Summary
    Note

    Note

    Note

    Bookmark

    print

    Print

    Remedium Lifecare Launches BSE-Approved Rights Issue to Fuel Pharma Innovation Remedium Lifecare Limited announces its BSE-approved Rights Issue, set to accelerate its mission of becoming a research-driven pharmaceutical powerhouse.

    Mumbai (Maharashtra) [India], April 29: Remedium Lifecare Limited (BSE: 539561) has announced the launch of its much-anticipated Rights Issue, which has received approval from the Bombay Stock Exchange (BSE). This strategic initiative marks a significant step in the company’s journey toward becoming a vertically integrated, research-driven pharmaceutical leader. The Rights Issue will open on April 30, 2025, and close on May 14, 2025.

    The capital raise comes on the heels of Remedium’s recent ₹182.7 crore agreement with a prominent UK-based pharmaceutical company, underscoring its commitment to international expansion. The funds raised will be utilised to strengthen working capital, invest in R&D capabilities, scale up the production of high-value pharmaceutical intermediates, attract top talent, drive digital transformation, and accelerate global market penetration.

    Speaking on the development, Mr. Adarsh Munjal, Managing Director of Remedium Lifecare Limited, commented: "This Rights Issue represents a significant milestone in our journey to become a globally recognised, innovation-led pharmaceutical company. The capital infusion will strengthen our strategic partnerships across domestic and international markets, with a particular focus on Europe and Asia." He also added that “It offers an exciting opportunity for investors to subscribe to the offer within the specified period and enhance their stake in the company at a potentially attractive price.” A substantial portion of the proceeds will be directed toward the establishment of advanced research laboratories specialising in Central Nervous System (CNS) disorders, metabolic conditions, and oncology—three of the most critical and high-demand therapeutic segments worldwide. The capital raise will also support prepayment, improving financial resilience.

    This initiative not only amplifies Remedium Lifecare’s operational and research capabilities but also supports India’s growing reputation as a reliable pharmaceutical manufacturing and supply chain hub. Through continued investments in high-quality infrastructure and cutting-edge R&D, the company is aligned with the national ‘Make in India’ initiative, while contributing to job creation and sustainable sectoral growth.

    Backed by a robust growth strategy, strong global partnerships, and an expanding innovation pipeline, Remedium Lifecare is well-positioned as an attractive opportunity for investors seeking long-term value in India’s rapidly expanding pharmaceutical and healthcare landscape.

    Key Highlights of the Rights Issue: • Closing Price: ₹ 1.79 as on 25th April 2025 • Right issue price: ₹ 1 per share • Ratio: 61 Rights Equity Shares for every 50 Equity Shares held on the Record Date • Record Date: Tuesday, April 15, 2025 • Rights Issue Opening Date: Wednesday, 30th April 2025 • Rights Issue Closing Date: Wednesday, 14th May 2025 • Renunciation of Rights Entitlement Period: 30th April to 9th May 2025 • Rights Issue Size: ₹ 49.19 crores About Remedium Lifecare Ltd.: Founded in 1988, Remedium Lifecare Ltd. is a BSE-listed pharmaceutical company engaged in the trading and distribution of raw material as a supply chain management for the pharmaceutical industry with an emphasis on quality, compliance, and global reach, the company continues to expand its presence while playing a pivotal role in India’s pharmaceutical ecosystem.

    For more Information, contact: Adarsh Munjal at Info@remediumlifecare.com (Disclaimer: The above press release comes to you under an arrangement with PNN and PTI takes no editorial responsibility for the same.). PTI PWR PWR

    Topics

    ActsIncome Tax